Community by and for patients to share experiences and recommendations

Morr F A New Hair Loss Solution

11/19/2018 7:08:44 PM

It is common knowledge that the only two medications that have been proven to be effective at treating genetic hair loss are Rogaine (minoxidil) and Propecia (finasteride). While treatments like Nizoral (ketoconazole) have been shown to be somewhat effective in treating hair loss, to date there have been no other medications or treatments approved by the FDA. In this article, we will discussing Morr F a topical hair loss solution.

What is Morr F?

Morr F is a topical hair loss solution that combines both Minoxidil and Finasteride, the exact formulation varies from 5% minoxidil to 10% Minoxidil, but finasteride is always 0.1%. While the use of topical finasteride remains to be a heavily debated topic amongst hair loss sufferers and professionals alike, there have been anecdotal and clinical  studies that suggest that finasteride can be effective when absorbed topically.

What Do the Clinical Studies Say About Morr F?

Unfortunately, the study available only tested a small group of 50 males aged 20-40 years old with androgenic alopecia (genetic hair loss). All of the participants were all previously treated with topical Minoxidil and oral Finasteride for a period of two years before entering the study. Five of the participants discontinued the treatment for a period of eight to twelve months for an undisclosed reason, but resumed the treatment after stopping.  Out of the forty five participants who underwent continous treatment for genetic hair loss, 84.4% maintained their hair density with the topical Minoxidil-Finasteride combination.

What About Side Effects?

Unfortunately, the study did not go in to detail whether or not any of the forty five participants experienced any adverse effects from the treatment. However, systemic absorbtion does occur with topical application. Therefore, topical and oral Finasteride may potentially cause adverse effects in some individuals. However, the incidence rate may be significantly decreased with applying the drug topically. Sadly, there are no studies that compare the incidence rate of adverse effects from topical Finasteride in comparison to oral Finasteride.

Conclusion

While the idea of localized topical treatment without any adverse effects sounds enticing, the truth of the matter is that some systemic absorbtion will always occur. However, the Minoxidil-Finasteride topical combination sounds promising and has been shown to at least maintain the same hair density when compared to the typical topical Minoxidil and oral Finasteride combination. Ultimately, more clinical studies are needed to compare the incidence of adverse effects and efficacy of the topical minoxidil-finasteride combination, but the studies available are promising.

Written and published by,

Melvin- Editorial Assistant and Forum Co-Moderator for the Hair Transplant Network and The Coalition of Independent Hair Restoration Physicians